Tokyo Tape
Sign in
← Immuno-Biological Laboratories

Quarterly report · Q1

4570.TEDINET S100OZBI
Period2022-04-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥156m2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥648m2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥125m2021-04-01 → 2021-06-30Cons.Net sales
Operating income−¥15m2022-04-01 → 2022-06-30Cons.Operating income
Operating income−¥74m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income−¥55m2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥243m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥102m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax−¥57m2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥109m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)−¥59m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥259m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥111m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income−¥59m2022-04-01 → 2022-06-30Cons.Profit loss
Net income−¥111m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥1.6bnat 2022-06-30Cons.Assets
Total assets¥1.7bnat 2022-03-31Cons.Assets
Total assets¥1.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥340mat 2022-06-30Cons.Liabilities
Total liabilities¥337mat 2022-03-31Cons.Liabilities
Net assets / equity¥1.3bnat 2022-06-30Cons.Net assets
Net assets / equity¥1.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥1.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥463mat 2022-06-30Cons.Cash and deposits
Cash and deposits¥508mat 2022-03-31Cons.Cash and deposits
EPS (basic)¥-6.322022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-27.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-11.892021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio79.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio88.8%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 25
SegmentItemPeriodValue
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue2022-04-01 → 2022-06-30¥829,000
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue external2022-04-01 → 2022-06-30¥829,000
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentsegment profit2022-04-01 → 2022-06-30−¥5m
jpcrp040300-q1r_E00986-000Gene Recombination Silkworm Developmentreportable segmentsegment profit2022-04-01 → 2022-06-30−¥19m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥156m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥156m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥9m
—segment totalrevenue2022-04-01 → 2022-06-30¥156m
—segment totalrevenue external2022-04-01 → 2022-06-30¥156m
—segment totalsegment profit2022-04-01 → 2022-06-30−¥15m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥2m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥2m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30¥240,000
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue external2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentsegment profit2021-04-01 → 2021-06-30−¥4m
jpcrp040300-q1r_E00986-000Gene Recombination Silkworm Developmentreportable segmentsegment profit2021-04-01 → 2021-06-30−¥29m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥125m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥123m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30−¥41m
—segment totalrevenue2021-04-01 → 2021-06-30¥127m
—segment totalrevenue external2021-04-01 → 2021-06-30¥125m
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥2m
—segment totalsegment profit2021-04-01 → 2021-06-30−¥74m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 307
ItemContextValueUnit
LiabilitiesPrior1YearInstant336990000JPY
LiabilitiesCurrentQuarterInstant340133000JPY
Capital stockPrior1YearInstant3029041000JPY
Capital stockCurrentQuarterInstant3029041000JPY
Capital surplusPrior1YearInstant2061421000JPY
Capital surplusCurrentQuarterInstant2061421000JPY
Retained earningsPrior1YearInstant-3720124000JPY
Retained earningsCurrentQuarterInstant-3779062000JPY
Treasury stockPrior1YearInstant-1990000JPY
Treasury stockCurrentQuarterInstant-1990000JPY
Shareholders equityPrior1YearInstant1368348000JPY
Shareholders equityCurrentQuarterInstant1309411000JPY
Net assetsPrior1YearInstant1368348000JPY
Net assetsCurrentQuarterInstant1309411000JPY
Liabilities and net assetsPrior1YearInstant1705338000JPY
Liabilities and net assetsCurrentQuarterInstant1649544000JPY
Net salesPrior1YTDDuration125150000JPY
Net salesCurrentYTDDuration156456000JPY
Cost of salesPrior1YTDDuration59479000JPY
Cost of salesCurrentYTDDuration59991000JPY
Gross profitPrior1YTDDuration65671000JPY
Gross profitCurrentYTDDuration96465000JPY
Selling general and administrative expensesPrior1YTDDuration139565000JPY
Selling general and administrative expensesCurrentYTDDuration111323000JPY
Operating incomePrior1YTDDuration-73893000JPY
Operating incomeCurrentYTDDuration-14858000JPY
Interest income noiPrior1YTDDuration5000JPY
Interest income noiCurrentYTDDuration274000JPY
Foreign exchange gains noiPrior1YTDDuration－JPY
Foreign exchange gains noiCurrentYTDDuration5661000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration3107000JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration4061000JPY
Other noiPrior1YTDDuration1818000JPY
Other noiCurrentYTDDuration100000JPY
Non operating incomePrior1YTDDuration4932000JPY
Non operating incomeCurrentYTDDuration10098000JPY
Interest expenses noePrior1YTDDuration40000JPY
Interest expenses noeCurrentYTDDuration265000JPY
Foreign exchange losses noePrior1YTDDuration319000JPY
Foreign exchange losses noeCurrentYTDDuration－JPY
Equity in losses of affiliates noePrior1YTDDuration32319000JPY
Equity in losses of affiliates noeCurrentYTDDuration49199000JPY
Other noePrior1YTDDuration－JPY
Other noeCurrentYTDDuration506000JPY
Non operating expensesPrior1YTDDuration32679000JPY
Non operating expensesCurrentYTDDuration49972000JPY
Ordinary incomePrior1YTDDuration-101640000JPY
Ordinary incomeCurrentYTDDuration-54731000JPY
Loss on valuation of investment securities elPrior1YTDDuration－JPY
Loss on valuation of investment securities elCurrentYTDDuration1108000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass